Daiichi Sankyo's mission is “to contribute to the enrichment of quality of life around the world through the creation of innovative pharmaceuticals and through the provision of pharmaceuticals addressing diverse medical needs."

Internal and external forces continue to reshape the pharmaceuticals sector as we know it. Therefore, we are deploying a Hybrid Business Model to materialize our vision of “becoming a Global Pharma Innovator." We will satisfy unmet medical needs as an innovative pharmaceuticals manufacturer. We will also deliver comprehensive healthcare services by developing a new business model that extends beyond a conventional pharmaceuticals business to vaccines, generic drugs, and over-the-counter treatments.

We have two key duties as a member of the healthcare industry. The first is to improve our operating results and contribute to the economy. The second is to assume an active role in the healthcare system. We intend to fulfill these duties to the absolute best of our ability as we earnestly do our utmost as a leading Japanese and world-class enterprise to earn the trust of all our stakeholders.

Joji Nakayama
Representative Director, President and CEO